世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000042595

転移性骨疾患の世界市場レポート(2025年)

The Business Research Company

Metastatic Bone Disease Global Market Report 2025

発刊日 2025/04/01

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000042595

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、転移性骨疾患の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている転移性骨疾患市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 治療別
      ◇ 薬物療法
      ◇ 放射線治療
      ◇ 外科的介入
      ◇ 腫瘍アブレーション療法
    ➣ 起源別
      ◇ 胸
      ◇ 肺
      ◇ 甲状腺
      ◇ 腎臓
      ◇ 前立腺
      ◇ その他の起源
    ➣ エンドユーザー別
      ◇ 病院
      ◇ 専門クリニック
      ◇ 外来手術センター
  • サブセグメント
    ➣ 薬物療法の種類別
      ◇ ビスホスホネート
      ◇ デノスマブ
      ◇ 化学療法薬
      ◇ ホルモン療法
      ◇ 標的療法
      ◇ 放射線治療
    ➣ 放射線治療の種類別
      ◇ 外部放射線療法
      ◇ 内部放射線療法
    ➣ 外科的介入の種類別
      ◇ 骨安定化手術
      ◇ 骨切除手術
      ◇ 脊椎減圧手術
    ➣ 腫瘍アブレーション療法の種類別
      ◇ 高周波アブレーション
      ◇ 凍結療法
      ◇ マイクロ波アブレーション
  • 調査企業
    ➣ Pfizer Inc.
    ➣ Johnson & Johnson
    ➣ Roche Holding AG
    ➣ Merck & Co. Inc.
    ➣ Bayer AG
  • 調査国
    オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ、カナダ、イタリア、スペイン
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Metastatic Bone Disease Market Characteristics

3. Metastatic Bone Disease Market Trends And Strategies

4. Metastatic Bone Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On Te Market

5. Global Metastatic Bone Disease Growth Analysis And Strategic Analysis Framework
5.1. Global Metastatic Bone Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Metastatic Bone Disease Market Growth Rate Analysis
5.4. Global Metastatic Bone Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Metastatic Bone Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Metastatic Bone Disease Total Addressable Market (TAM)

6. Metastatic Bone Disease Market Segmentation
6.1. Global Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Radiation Therapy
Surgical Intervention
Tumor Ablation Therapy
6.2. Global Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast
Lung
Thyroid
Kidney
Prostate
Other Origins
6.3. Global Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
6.4. Global Metastatic Bone Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bisphosphonates
Denosumab
Chemotherapy Drugs
Hormonal Therapies
Targeted Therapies
Radiation Therapy
6.5. Global Metastatic Bone Disease Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
External Beam Radiation Therapy
Internal Radiation Therapy
6.6. Global Metastatic Bone Disease Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bone Stabilization Surgery
Bone Resection Surgery
Spinal Decompression Surgery
6.7. Global Metastatic Bone Disease Market, Sub-Segmentation Of Tumor Ablation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Radiofrequency Ablation
Cryoablation
Microwave Ablation

7. Metastatic Bone Disease Market Regional And Country Analysis
7.1. Global Metastatic Bone Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Metastatic Bone Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metastatic Bone Disease Market
8.1. Asia-Pacific Metastatic Bone Disease Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metastatic Bone Disease Market
9.1. China Metastatic Bone Disease Market Overview
9.2. China Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metastatic Bone Disease Market
10.1. India Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metastatic Bone Disease Market
11.1. Japan Metastatic Bone Disease Market Overview
11.2. Japan Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metastatic Bone Disease Market
12.1. Australia Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metastatic Bone Disease Market
13.1. Indonesia Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metastatic Bone Disease Market
14.1. South Korea Metastatic Bone Disease Market Overview
14.2. South Korea Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metastatic Bone Disease Market
15.1. Western Europe Metastatic Bone Disease Market Overview
15.2. Western Europe Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metastatic Bone Disease Market
16.1. UK Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metastatic Bone Disease Market
17.1. Germany Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metastatic Bone Disease Market
18.1. France Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metastatic Bone Disease Market
19.1. Italy Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metastatic Bone Disease Market
20.1. Spain Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metastatic Bone Disease Market
21.1. Eastern Europe Metastatic Bone Disease Market Overview
21.2. Eastern Europe Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metastatic Bone Disease Market
22.1. Russia Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metastatic Bone Disease Market
23.1. North America Metastatic Bone Disease Market Overview
23.2. North America Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metastatic Bone Disease Market
24.1. USA Metastatic Bone Disease Market Overview
24.2. USA Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metastatic Bone Disease Market
25.1. Canada Metastatic Bone Disease Market Overview
25.2. Canada Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metastatic Bone Disease Market
26.1. South America Metastatic Bone Disease Market Overview
26.2. South America Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metastatic Bone Disease Market
27.1. Brazil Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metastatic Bone Disease Market
28.1. Middle East Metastatic Bone Disease Market Overview
28.2. Middle East Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metastatic Bone Disease Market
29.1. Africa Metastatic Bone Disease Market Overview
29.2. Africa Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metastatic Bone Disease Market Competitive Landscape And Company Profiles
30.1. Metastatic Bone Disease Market Competitive Landscape
30.2. Metastatic Bone Disease Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Metastatic Bone Disease Market Other Major And Innovative Companies
31.1. Sanofi SA
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca plc
31.4. Novartis AG
31.5. GSK plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Medtronic plc
31.8. Eli Lilly and Company
31.9. Amgen Inc.
31.10. Boston Scientific Corporation
31.11. Regeneron Pharmaceuticals Inc.
31.12. Astellas Pharma Inc.
31.13. Daiichi Sankyo Company Limited
31.14. Jazz Pharmaceuticals Inc.
31.15. Exelixis Inc.

32. Global Metastatic Bone Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metastatic Bone Disease Market

34. Recent Developments In The Metastatic Bone Disease Market

35. Metastatic Bone Disease Market High Potential Countries, Segments and Strategies
35.1 Metastatic Bone Disease Market In 2029 - Countries Offering Most New Opportunities
35.2 Metastatic Bone Disease Market In 2029 - Segments Offering Most New Opportunities
35.3 Metastatic Bone Disease Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2019-2024, $ Billion
Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
Table 3: Global Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 4: Global Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 5: Global Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 6: Global Metastatic Bone Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 7: Global Metastatic Bone Disease Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 8: Global Metastatic Bone Disease Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 9: Global Metastatic Bone Disease Market, Sub-Segmentation Of Tumor Ablation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 10: Global Metastatic Bone Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 11: Global Metastatic Bone Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 12: Asia-Pacific, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 13: Asia-Pacific, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 14: Asia-Pacific, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 15: China, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 16: China, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 17: China, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 18: India, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 19: India, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 20: India, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 21: Japan, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 22: Japan, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 23: Japan, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 24: Australia, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 25: Australia, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 26: Australia, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 27: Indonesia, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 28: Indonesia, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 29: Indonesia, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 30: South Korea, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 31: South Korea, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 32: South Korea, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 33: Western Europe, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 34: Western Europe, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 35: Western Europe, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 36: UK, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 37: UK, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 38: UK, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 39: Germany, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 40: Germany, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 41: Germany, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 42: France, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 43: France, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 44: France, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 45: Italy, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 46: Italy, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 47: Italy, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 48: Spain, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 49: Spain, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 50: Spain, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 51: Eastern Europe, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 52: Eastern Europe, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 53: Eastern Europe, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 54: Russia, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 55: Russia, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 56: Russia, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 57: North America, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 58: North America, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 59: North America, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 60: USA, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 61: USA, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 62: USA, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 63: Canada, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 64: Canada, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 65: Canada, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 66: South America, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 67: South America, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 68: South America, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 69: Brazil, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 70: Brazil, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 71: Brazil, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 72: Middle East, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 73: Middle East, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 74: Middle East, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 75: Africa, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 76: Africa, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 77: Africa, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Table 78: Pfizer Inc. Financial Performance
Table 79: Johnson & Johnson Financial Performance
Table 80: Roche Holding AG Financial Performance
Table 81: Merck & Co. Inc. Financial Performance
Table 82: Bayer AG Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
Figure 3: Global Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 4: Global Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 5: Global Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 6: Global Metastatic Bone Disease Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 7: Global Metastatic Bone Disease Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 8: Global Metastatic Bone Disease Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 9: Global Metastatic Bone Disease Market, Sub-Segmentation Of Tumor Ablation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 10: Global Metastatic Bone Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 11: Global Metastatic Bone Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 12: Asia-Pacific, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 13: Asia-Pacific, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 14: Asia-Pacific, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 15: China, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 16: China, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 17: China, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 18: India, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 19: India, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 20: India, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 21: Japan, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 22: Japan, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 23: Japan, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 24: Australia, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 25: Australia, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 26: Australia, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 27: Indonesia, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 28: Indonesia, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 29: Indonesia, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 30: South Korea, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 31: South Korea, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 32: South Korea, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 33: Western Europe, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 34: Western Europe, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 35: Western Europe, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 36: UK, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 37: UK, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 38: UK, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 39: Germany, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 40: Germany, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 41: Germany, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 42: France, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 43: France, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 44: France, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 45: Italy, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 46: Italy, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 47: Italy, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 48: Spain, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 49: Spain, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 50: Spain, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 51: Eastern Europe, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 52: Eastern Europe, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 53: Eastern Europe, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 54: Russia, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 55: Russia, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 56: Russia, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 57: North America, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 58: North America, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 59: North America, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 60: USA, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 61: USA, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 62: USA, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 63: Canada, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 64: Canada, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 65: Canada, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 66: South America, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 67: South America, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 68: South America, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 69: Brazil, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 70: Brazil, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 71: Brazil, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 72: Middle East, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 73: Middle East, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 74: Middle East, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 75: Africa, Metastatic Bone Disease Market, Segmentation By Treatment , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 76: Africa, Metastatic Bone Disease Market, Segmentation By Origin , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 77: Africa, Metastatic Bone Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Figure 78: Pfizer Inc. Financial Performance
Figure 79: Johnson & Johnson Financial Performance
Figure 80: Roche Holding AG Financial Performance
Figure 81: Merck & Co. Inc. Financial Performance
Figure 82: Bayer AG Financial Performance

この商品のレポートナンバー

0000042595

TOP